{
    "organizations": [],
    "uuid": "078369224c98de73ad70922dd85c71b95059f1a9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ortho-dermatologics-says-us-fda-fi/brief-ortho-dermatologics-says-u-s-fda-filing-acceptance-for-jemdel-plaque-psoriasis-treatment-idUSFWN1Q413T",
    "ord_in_thread": 0,
    "title": "BRIEF-Ortho Dermatologics Says U.S. FDA Filing Acceptance For Jemdel Plaque Psoriasis Treatment",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Valeant Pharmaceuticals International Inc :\n* ORTHO DERMATOLOGICS ANNOUNCES U.S. FDA FILING ACCEPTANCE FOR JEMDEL™ PLAQUE PSORIASIS TREATMENT\n* ‍ORTHO DERMATOLOGICS - FDA ACCEPTED NEW DRUG APPLICATION FOR JEMDEL LOTION WITH A PDUFA ACTION DATE OF OCT 5, 2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T20:06:00.000+02:00",
    "crawled": "2018-02-15T20:40:45.035+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "valeant",
        "pharmaceutical",
        "international",
        "inc",
        "ortho",
        "dermatologics",
        "announces",
        "fda",
        "filing",
        "acceptance",
        "plaque",
        "psoriasis",
        "treatment",
        "dermatologics",
        "fda",
        "accepted",
        "new",
        "drug",
        "application",
        "jemdel",
        "lotion",
        "pdufa",
        "action",
        "date",
        "oct",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}